Is Medibank Private Ltd really worth that much?

Despite its somewhat lofty valuation, it has been suggested that the Medibank Private Ltd (ASX:MPL) stock could still have a long way to go before it cools the jets

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite its somewhat lofty valuation, it has been suggested that the Medibank Private Ltd (ASX: MPL) share price could still have a long way to go before it cools its jets.

As it stands, the stock is trading at $2.39 on a price-earnings ratio of 25.5 times financial year 2014 earnings. While retail investors received shares for $2.00 in the November float, the stock has since traded between a range of $2.08 and $2.44.

At its current price, many analysts and investors have become cautious of just how expensive the stock is. While Medibank is a good company, it would need to cut costs and improve efficiencies considerably to justify its high price tag.

Yet despite these views, one broker has given the stock a price target of $2.62 while another analyst from Bank of America Merrill Lynch (BoAML) has said the stock could be worth as much as $3.00. Those two targets would suggest that Medibank's shares could still have between 9.6% and 25.5% left to climb.

Of course, anything is possible. If management quickly pulls through on its promise to improve administrative costs then the stock could certainly reach for those heights. But then again, a lot of hype is already priced into the shares, so should management fall short on the market's expectations, the stock could just as likely retreat – heavily.

While it's always encouraging to have the 'experts' talking a stock up, there is certainly no guarantee that their forecasts will be correct. Right now, there is little margin of safety for investors who decide to buy Medibank shares, meaning that they could be assuming an unnecessarily high level of risk.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned. You can follow Ryan on Twitter @ASXvalueinvest.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »